The power to manage your diabetes with confidence
Make better treatment decisions in the moment without finger pricks.*
*Finger pricks required for diabetes treatment decisions if symptoms or expectations do not match readings.
The Dexcom CGM Difference
Pioneer and leader in Real-Time CGM, Dexcom's goal is to simplify and improve diabetes management for every possible person with diabetes.
Real-time Glucose Readings.
No finger pricks*. No scanning.
Exceptional Accuracy†
Better informed treatment desicions.‡
Intuitive features.
Customisable alerts.
Proven Results.
Lower HbA1C. More time-in-range.1-5
Find the right Dexcom CGM for you
Whatever your diabetes needs are, we have a Real-Time CGM for you. Explore our range of products.
CGM made more accessible
Best for people with type 1 or type 2 diabetes using insulin looking for an easy and accessible real-time CGM system.
Powerful and connected CGM.
Best for people with type 1 diabetes who may need extra support, such as people who are hypo unaware, pregnant or children, and those that want connectivity with insulin delivery systems and health or lifestyle apps.
Dexcom CGM can be offered to people with type 1 diabetes on prescription.
References:
* Finger pricks required for diabetes treatment decisions if symptoms or expectations do not match readings.
‡ Discuss with your HCP on how to use CGM information to manage diabetes.
# Results obtained with a prior generation Dexcom CGM system.
1 See user guide G6, G7 and Dexcom ONE
2 Beck RW, et al. JAMA. 2017;317(4):371-378.
3 Beck RW, et al. Ann Intern Med. 2017;167(6):365-374.
4 Šoupal J, et al. Diabetes Care. 2020;43:37-43.
5 Welsh JB, et al. J Diabetes Sci Technol. 2022:19322968221099879.
‡ Discuss with your HCP on how to use CGM information to manage diabetes.
# Results obtained with a prior generation Dexcom CGM system.
1 See user guide G6, G7 and Dexcom ONE
2 Beck RW, et al. JAMA. 2017;317(4):371-378.
3 Beck RW, et al. Ann Intern Med. 2017;167(6):365-374.
4 Šoupal J, et al. Diabetes Care. 2020;43:37-43.
5 Welsh JB, et al. J Diabetes Sci Technol. 2022:19322968221099879.